Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on America Latina Times.
Press releases published on July 31, 2025
Supernus Pharmaceuticals Completes Acquisition of Sage Therapeutics
GlobeNewswire
·
July 31, 2025
ROCKVILLE, Md., July 31, 2025 (GLOBE NEWSWIRE) -- Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN) (“Supernus”) today announced that it has successfully completed its previously announced acquisition of Sage Therapeutics, Inc. (Nasdaq: SAGE) (“Sage”). “Sage …
Quoin Pharmaceuticals to Announce Second Quarter 2025 Financial Results on Thursday, August 7, 2025
GlobeNewswire
·
July 31, 2025
ASHBURN, Va., July 31, 2025 (GLOBE NEWSWIRE) -- Quoin Pharmaceuticals Ltd. (NASDAQ: QNRX) (the "Company" or "Quoin"), a late clinical-stage specialty pharmaceutical company focused on rare and orphan diseases, today announced that it plans to release its …
Oragenics Selects Southern Star Research as Clinical Research Organization for ONP-002 Phase IIa Trial
GlobeNewswire
·
July 31, 2025
SARASOTA, Fla., July 31, 2025 (GLOBE NEWSWIRE) -- Oragenics, Inc. (NYSE American: OGEN), a clinical-stage biotechnology company pioneering intranasal drug delivery for neurological conditions, today announced the selection of Southern Star Research as its …
June 2025 Quarterly Activities Report
GlobeNewswire
·
July 31, 2025
QUEBEC CITY, July 31, 2025 (GLOBE NEWSWIRE) -- West African gold producer and developer Robex Resources Inc (“Robex” or the “Company”) (TSX-V: RBX | ASX: RXR | OTC: RSRBF | Börse Frankfurt: RB4) is pleased to report on its June 2025 Quarter Activities. …
Lisata Therapeutics to Report Second Quarter 2025 Financial Results and Provide a Business Update on Thursday, August 7, 2025
GlobeNewswire
·
July 31, 2025
BASKING RIDGE, N.J., July 31, 2025 (GLOBE NEWSWIRE) -- Lisata Therapeutics, Inc. (Nasdaq: LSTA) (“Lisata” or the “Company”), a clinical-stage pharmaceutical company developing innovative therapies for the treatment of advanced solid tumors and other …
Banco Santander-Chile Announces Second Quarter 2025 Earnings
GlobeNewswire
·
July 31, 2025
SANTIAGO, Chile, July 31, 2025 (GLOBE NEWSWIRE) -- Banco Santander Chile (NYSE: BSAC; SSE: Bsantander) announced today its results1 for the six-month period ended June 30, 2025, and second quarter 2025 (2Q25). Solid financial performance with a ROAE2 of 24 …
Nautilus Biotechnology Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
July 31, 2025
SEATTLE, July 31, 2025 (GLOBE NEWSWIRE) -- Nautilus Biotechnology, Inc. (NASDAQ: NAUT; or “Nautilus”), a company pioneering a single-molecule proteome analysis platform, today reported financial results for the second quarter ended June 30, 2025. “In Q2, …
Discovery Announces Senior Management Appointment
GlobeNewswire
·
July 31, 2025
TORONTO, July 31, 2025 (GLOBE NEWSWIRE) -- Discovery Silver Corp. (TSX: DSV, OTCQX: DSVSF) (“Discovery” or the “Company”) today announced the appointment of Alison White to the position of Chief Financial Officer (“CFO”). The appointment is effective …
Crescent Biopharma Reports Second Quarter 2025 Financial Results and Recent Business Highlights
GlobeNewswire
·
July 31, 2025
Completed Merger with GlycoMimetics and Previously Announced $200 Million Private Financing Supporting Pipeline of Next Generation Therapeutics for Solid Tumors Recent Leadership Appointments Bring Deep Experience in Oncology Drug Development, Clinical …
Effective Date of Consolidation of Shares
GlobeNewswire
·
July 31, 2025
Vancouver, British Columbia , July 31, 2025 (GLOBE NEWSWIRE) -- First American Uranium Inc. (CSE: URM) (FSE: IOR) (OTCPK: FAUMF) (the “Company”) announces, further to its news release of July 21, 2025 and effective August 6, 2025, the Company will …
InflaRx to Report Second Quarter 2025 Results on August 7, 2025
GlobeNewswire
·
July 31, 2025
JENA, Germany, July 31, 2025 (GLOBE NEWSWIRE) -- InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics by targeting the complement system, today announced that the Company will report its second quarter 2025 …
Osisko Development Announces US$195 Million Financing
GlobeNewswire
·
July 31, 2025
Not for distribution to U.S. news wire services or dissemination in the United States. MONTREAL, July 31, 2025 (GLOBE NEWSWIRE) -- Osisko Development Corp. (NYSE: ODV, TSXV: ODV) ("Osisko Development" or the "Company") announces today that it has entered …
Apellis Pharmaceuticals Reports Second Quarter 2025 Financial Results
GlobeNewswire
·
July 31, 2025
Received U.S. FDA approval for EMPAVELI® (pegcetacoplan) for treatment of patients 12 years and older with C3G and primary IC-MPGN Announced capped royalty purchase agreement with Sobi under which Apellis receives up to $300 million for 90% of ex-U.S. …
BioCryst Announces Charlie Gayer to Succeed Jon Stonehouse as Chief Executive Officer Upon his Retirement in December
GlobeNewswire
·
July 31, 2025
RESEARCH TRIANGLE PARK, N.C., July 31, 2025 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that its president and chief executive officer, Jon Stonehouse, has informed the board of directors of his intention to retire on …
Medicenna Strengthens Intellectual Property Portfolio with Five Patents Granted for its IL-2 and IL-4 Superkines
GlobeNewswire
·
July 31, 2025
TORONTO and HOUSTON, July 31, 2025 (GLOBE NEWSWIRE) -- Medicenna Therapeutics Corp. (“Medicenna” or the “Company”) (TSX: MDNA, OTCQX: MDNAF), a clinical-stage immunotherapy company developing novel Superkines for oncology and autoimmune diseases, today …
Oroco Deepens its ESG Commitments to the Santo Tomás Region
GlobeNewswire
·
July 31, 2025
VANCOUVER, Canada, July 31, 2025 (GLOBE NEWSWIRE) -- Oroco Resource Corp. (TSX-V: OCO; OTC: ORRCF) (“Oroco” or “the Company”) is pleased to announce it has signed a cooperation agreement with Sembrando Vida (“Sowing Life”), a flagship environmental and …
Brookfield Infrastructure Reports Solid Second Quarter 2025 Results
GlobeNewswire
·
July 31, 2025
BROOKFIELD, News, July 31, 2025 (GLOBE NEWSWIRE) -- Brookfield Infrastructure Partners L.P. (Brookfield Infrastructure, BIP, or the Partnership) (NYSE: BIP; TSX: BIP.UN) today announced its results for the second quarter ended June 30, 2025. “We had an …
XORTX Announces USD $114,500 Private Placement
GlobeNewswire
·
July 31, 2025
CALGARY, Alberta, July 31, 2025 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. (“XORTX” or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a late stage clinical pharmaceutical company focused on developing innovative therapies to treat gout and …
Voluntary TSX delisting application
GlobeNewswire
·
July 31, 2025
TORONTO, July 31, 2025 (GLOBE NEWSWIRE) -- Xanadu Mines Ltd (ASX:XAM, TSX:XAM) ACN 114 249 026 (Xanadu or the Company) refers to its previous announcement released on 29 July 2025 (Announcement) regarding the Compulsory Acquisition Notice provided by …
Agios Reports Second Quarter 2025 Financial Results and Provides Business Update
GlobeNewswire
·
July 31, 2025
$12.5 million in second quarter PYRUKYND® (mitapivat) net revenues; ended second quarter with $1.3 billion dollars in cash, cash equivalents and marketable securities PYRUKYND sNDA for thalassemia under active review, with FDA PDUFA goal date of September …